Business Description
Genkyotex SA
ISIN : FR0013399474
Compare
Compare
Traded in other countries / regions
IPO Date
2014-04-03Description
Genkyotex SA is a biopharmaceutical company. It is engaged in the business of research, study, manufacturing and distribution of medicines, drug and health products in the field of human and animal health. The firm is involved in the development of immunotherapies and therapeutic vaccines designed to treat women for cervical cancer. Its products include vaxiclase technological platform and GTL001 and GTL002. The company has the Development of immunotherapies segment.
Financial Strength
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 6.54 | |||||
| Equity-to-Asset | 0.32 | |||||
| Debt-to-Equity | 0.12 | |||||
| Debt-to-EBITDA | -0.01 | |||||
| Piotroski F-Score | 1/9 | |||||
| Beneish M-Score | -9.82 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | 32.2 | |||||
| 3-Year EPS without NRI Growth Rate | 31.5 | |||||
| 3-Year FCF Growth Rate | 28.9 | |||||
| 3-Year Book Growth Rate | -60.3 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 6-1 Month Momentum % | 14.82 | |||||
| 12-1 Month Momentum % | 9.75 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 0.92 | |||||
| Quick Ratio | 0.92 | |||||
| Cash Ratio | 0.46 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -21.7 |
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| ROE % | -300.35 | |||||
| ROA % | -190.05 | |||||
| ROIC % | -306.99 | |||||
| ROC (Joel Greenblatt) % | -8661.68 | |||||
| ROCE % | -258.98 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PB Ratio | 23.06 | |||||
| EV-to-EBIT | -3.13 | |||||
| EV-to-EBITDA | -3.28 | |||||
| EV-to-FCF | -7.67 | |||||
| Earnings Yield (Greenblatt) % | -31.95 | |||||
| FCF Yield % | -21.43 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Genkyotex SA Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | |||
| EPS (TTM) (€) | -1.407 | ||
| Beta | 0 | ||
| Volatility % | 15.37 | ||
| 14-Day RSI | 0 | ||
| 14-Day ATR (€) | 0.0125 | ||
| 20-Day SMA (€) | 0 | ||
| 12-1 Month Momentum % | 9.75 | ||
| 52-Week Range (€) | 2.525 - 4.84 | ||
| Shares Outstanding (Mil) | 14.07 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 1 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Genkyotex SA Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Genkyotex SA Stock Events
| Event | Date | Price(€) | ||
|---|---|---|---|---|
| No Event Data | ||||
Genkyotex SA Frequently Asked Questions
What is Genkyotex SA(XPAR:GKTX)'s stock price today?
The current price of XPAR:GKTX is €3.21. The 52 week high of XPAR:GKTX is €4.84 and 52 week low is €2.53.
When is next earnings date of Genkyotex SA(XPAR:GKTX)?
The next earnings date of Genkyotex SA(XPAR:GKTX) is .
Does Genkyotex SA(XPAR:GKTX) pay dividends? If so, how much?
Genkyotex SA(XPAR:GKTX) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers